Abstract:Hemiparkinsonism duration in patients with Parkinson's disease (PD) is a key time window to study early pathology of PD. We aimed to comprehensively explore the alterations of deformation and structural network in PD patients with hemiparkinsonism, which could potentially disclose the early biomarker for PD. Thirty-one PD patients with hemiparkinsonism and 37 age- and gender- matched normal controls were included in the present study. First of all, we normalized the left hemisphere of structural images as the contralateral side to the affected limbs. Deformation-based morphometry (DBM) was conducted to evaluate the brain atrophy and/or enlargement. structural networks were constructed by thresholding gray matter volume correlation matrices of 116 regions and analyzed using graph theoretical approaches (e.g., small-worldness, global, and nodal measures). Significantly decreased deformation values were observed in the temporoparietal regions like bilateral middle temporal gyri, ipsilateral precuneus and contralateral Rolandic operculum extending to supramarginal and postcentral gyri. Lower deformation values in contralateral middle temporal gyrus were negatively correlated with higher motor impairment which was dominated by akinesia/rigidity. Moreover, nodal reorganization of structural network mainly located in frontal, temporal, subcortex and cerebellum was bilaterally explored in PD patients with hemiparkinsonism. Increased nodal properties could be commonly observed in frontal lobes. Disruption of subcortex including basal ganglia and amygdala was detected by nodal local efficiency and nodal clustering coefficient. Twelve hubs, mainly from paralimbic-limbic and heteromodal networks, were disrupted and, alternatively, 14 hubs, most of which were located in frontal lobes, were additionally detected in PD patients with hemiparkinsonism. In conclusion, during hemiparkinsonism period, mild brain atrophy in the temporoparietal regions and widespread reorganization of structural network, e.g., enhanced frontal function and disruption of basal ganglia nodes, occurred in both hemispheres. With our data, we can also argue that MTG contralateral to the affected limbs (expressing clinically verified brain atrophy) might be a potential living biomarker to monitor disease progression. Therefore, the combination of DBM and structural network analyses can provide a comprehensive and sensitive evaluation for potential pathogenesis of early PD patients with hemiparkinsonism.

Associations between Brain Structural Damage and Core Muscle Loss in Patients with Parkinson’s Disease

Disrupted morphological grey matter networks in early-stage Parkinson’s disease

Brain Atrophy and Reorganization of Structural Network in Parkinson's Disease with Hemiparkinsonism

Association Between Body Mass Index and Glymphatic Function Using Diffusion Tensor Image-along the Perivascular Space (DTI-ALPS) in Patients with Parkinson’s Disease

The Longitudinal Volumetric and Shape Changes of Subcortical Nuclei in Parkinson’s Disease

Differences in gray matter atrophy and functional connectivity between motor subtypes of Parkinson's disease

Reduced lateral occipital gray matter volume is associated with physical frailty and cognitive impairment in Parkinson's disease

Brain Structural Correlates of Depressive Symptoms in Parkinson's Disease Patients at Different Disease Stage.

Fiber-Specific White Matter Alterations in Parkinson's Disease

Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson's Disease

Different Patterns of Gray Matter Density in Early- and Middle-Late-onset Parkinson’s Disease: a Voxel-Based Morphometry Study

Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease

The Role of Brain Perivascular Space Burden in Early-Stage Parkinson’s Disease

Regional White Matter Hyperintensity Volume in Parkinson's Disease and Associations with the Motor Signs.

The Value of Ultrasound Measurement of Muscle Thickness at Different Sites and Shear Wave Elastography in Parkinson’s Disease with Sarcopenia: a Pilot Study

Structural and functional abnormalities in Parkinson’s disease based on voxel-based morphometry and resting-state functional magnetic resonance imaging

Gray Matter, White Matter and Cerebrospinal Fluid Abnormalities in Parkinson’s Disease: A Voxel-Based Morphometry Study

Brain atrophy and white matter hyperintensities in early Parkinson's disease(a)

Gray Matter Atrophy in Parkinson's Disease and the Parkinsonian Variant of Multiple System Atrophy: A Combined ROI- and Voxel-Based Morphometric Study

Altered microstructural properties of superficial white matter in patients with Parkinson’s disease

Brain Atrophy Mediates the Relationship between Misfolded Proteins Deposition and Cognitive Impairment in Parkinson’s Disease